CorFlow Therapeutics AG

About:

CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions.

Website: https://corflow.com/

Twitter/X: corflowthx

Top Investors: Innosuisse, Wellington Partners, 415 Capital, Unorthodox Ventures, KOFA Healthcare

Description:

CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complication rates in these patients.

Total Funding Amount:

$66.2M

Headquarters Location:

Baar, Zug, Switzerland

Founded Date:

2016-01-01

Contact Email:

contact(AT)corflow-therapeutics.ch

Founders:

Jon H. Hoem

Number of Employees:

11-50

Last Funding Date:

2024-09-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai